Resilience and response of the congenital cardiac network in Italy during the COVID-19 pandemic.


Journal

Journal of cardiovascular medicine (Hagerstown, Md.)
ISSN: 1558-2035
Titre abrégé: J Cardiovasc Med (Hagerstown)
Pays: United States
ID NLM: 101259752

Informations de publication

Date de publication:
01 2021
Historique:
pubmed: 3 8 2020
medline: 30 12 2020
entrez: 3 8 2020
Statut: ppublish

Résumé

: The worldwide response to the current COVID-19 pandemic has been focused on how to prevent the disease and to protect the high-risk patient from a potentially lethal infection. Several consensus and guidelines articles have been published dealing with the cardiac patient with systemic hypertension, heart transplant or heart failure. Very little is known about the patients, both in the pediatric as well as in the adult age, with congenital heart disease. The peculiar physiology of the heart with a native, repaired or palliated congenital heart defect deserves a specialized care. Hereby we describe the early recommendations issued by the Italian Society of Pediatric Cardiology and Congenital Heart Disease and how the network of the congenital cardiac institutions in Italy reacted to the threat of potential wide spread of the infection among this fragile kind of patient.

Identifiants

pubmed: 32740440
doi: 10.2459/JCM.0000000000001063
pii: 01244665-202101000-00002
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

9-13

Commentaires et corrections

Type : ErratumIn

Références

World Health Organization. WHO Director-General's opening remarks at the media briefing on COVID-19-11 March 2020. Available at: https://www.who.int/dg/speeches/detail/whodirector-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020 . [Accessed 24 April 2020]
Zheng YY, Ma YT, Zhang JY, Xie X. COVID-19 and the cardiovascular system. Nat Rev Cardiol 2020; 17:259–260.
Clerkin KJ, Fried JA, Raikhelkar J, et al. Coronavirus disease 2019 (COVID-19) and cardiovascular disease. Circulation 2020; 141:1648–1655.
Kochi AN, Tagliari AP, Forleo GB, Fassini GM, Tondo C. Cardiac and arrhythmic complications in patients with COVID-19. J Cardiovasc Electrophysiol 2020; 31:1003–1008.
Lippi G, Lavie C, Sanchis-Gomar F. Cardiac troponin I in patients with coronavirus disease 2019 (COVID-19): evidence from a meta-analysis. Prog Cardiovasc Dis 2020; doi:10.1016/j.pcad.2020.03.001.
doi: 10.1016/j.pcad.2020.03.001
Tavazzi G, Pellegrini C, Maurelli M, et al. Myocardial localization of coronavirus in COVID-19 cardiogenic shock. Eur J Heart Fail 2020; 22:911–915.
Zeng JH, Liu YX, Yuan J, et al. First case of COVID-19 complicated with fulminant myocarditis: a case report and insights. Infection 2020; 1–5. doi:10.1007/s15010-020-01424-5.
doi: 10.1007/s15010-020-01424-5
Campo G, Rapezzi C, Tavazzi L, Ferrari R. Priorities for Cath labs in the COVID-19 tsunami. Eur Heart J 2020; 41:1784–1785.
Welt FGP, Shah PB, Aronow HD, et al. American College of Cardiology's (ACC) Interventional Council and the Society of Cardiovascular Angiography and Intervention (SCAI). Catheterization laboratory considerations during the coronavirus (COVID-19) pandemic: from ACC's Interventional Council and SCAI. J Am Coll Cardiol 2020; 75:2372–2375.
Driggin E, Madhavan MV, Bikdeli B, et al. Cardiovascular considerations for patients, health care workers, and health systems during the COVID-19 pandemic. J Am Coll Cardiol 2020; 75:2352–2371.
Shah PB, Welt FGP, Mahmud E, et al. American College of Cardiology (ACC) and the Society for Cardiovascular Angiography and Interventions (SCAI). Triage considerations for patients referred for structural heart disease intervention during the COVID-19 pandemic: an ACC/SCAI position statement. JACC Cardiovasc Interv 2020; 13:1484–1488.
Drake D, Morrow CD, Kinlaw K, De Bonis M, Zangrillo A, Sade RM. Cardiothoracic Ethics Forum. Cardiothoracic surgeons in pandemics: ethical considerations. Ann Thorac Surg 2020; S0003-4975,30500-2. doi:10.1016/j.athoracsur.2020.03.006.
doi: 10.1016/j.athoracsur.2020.03.006
Henry BM, Lippi G. Poor survival with extracorporeal membrane oxygenation in acute respiratory distress syndrome (ARDS) due to coronavirus disease 2019 (COVID-19): pooled analysis of early reports. Crit Care 2020; 58:27–28.
Bartlett RH, Ogino MT, Brodie D, et al. Initial ELSO guidance document: ECMO for COVID-19 patients with severe cardiopulmonary failure. ASAIO J 2020; 66:472–474.
Angelos P. Surgeons, ethics, and COVID-19: early lessons learned. J Am Coll Surg 2020; 230:1119–1120.
Boyarsky BJ, Chiang TP, Werbel WA, et al. Early impact of COVID-19 on transplant center practices and policies in the United States. Am J Transplant 2020; 10.1111/ajt.15915. doi:10.1111/ajt.15915.
doi: 10.1111/ajt.15915.
Aslam S, Mehra MR. COVID-19: yet another coronavirus challenge in transplantation. J Heart Lung Transplant 2020; 39:408–409.
Morray BH, Gordon BM, Crystal MA, et al. Resource allocation and decision making for pediatric and congenital cardiac catheterization during the novel coronavirus SARS-CoV-2 (COVID-19) pandemic: a U.S. Multi-Institutional Perspective. J Invasive Cardiol 2020; 32:E103–E109.
Tan W, Aboulhosn J. The cardiovascular burden of coronavirus disease 2019 (COVID-19) with a focus on congenital heart disease. Int J Cardiol 2020; 309:70–77.
Stephens EH, Dearani JA, Guleserian KJ, et al. COVID-19: crisis management in congenital heart surgery. Ann Thorac Surg 2020; S0003-4975,30540-3. doi:10.1016/j.athoracsur.2020.04.001.
doi: 10.1016/j.athoracsur.2020.04.001
Lippi G, Simundic AM, Plebani M. Potential preanalytical and analytical vulnerabilities in the laboratory diagnosis of coronavirus disease 2019 (COVID-19). Clin Chem Lab Med 2020; 58:1070–1076.
Forrester JD, Nassar AK, Maggio PM, Hawn MT. Precautions for operating room team members during the COVID-19 pandemic. J Am Coll Surg 2020; 230:1098–1101.
Patel PD, Cobb J, Wright D, et al. Rapid development of telehealth capabilities within pediatric patient portal infrastructure for COVID-19 care: barriers, solutions, results. J Am Med Inform Assoc 2020; ocaa065doi:10.1093/jamia/ocaa065.
doi: 10.1093/jamia/ocaa065
Dong Y, Mo X, Hu Y, et al. Epidemiology of COVID-19 among children in China. Pediatrics 2020; 145:e20200702.
Lu X, Zhang L, Du H, et al. Chinese Pediatric Novel Coronavirus Study Team. SARS-CoV-2 infection in children. N Engl J Med 2020; 382:1663–1665.
Qiu H, Wu J, Hong L, Luo Y, Song Q, Chen D. Clinical and epidemiological features of 36 children with coronavirus disease 2019 (COVID-19) in Zhejiang, China: an observational cohort study. Lancet Infect Dis 2020; 20:689–696.
Yang H, Wang C, Poon LC. Novel coronavirus infection and pregnancy. Ultrasound Obstet Gynecol 2020; 55:435–437.
Dong L, Tian J, He S, et al. Possible vertical transmission of SARS-CoV-2 from an infected mother to her newborn. JAMA 2020; 323:1846–1848.
Shen K, Yang Y, Wang T, et al. Diagnosis, treatment, and prevention of 2019 novel coronavirus infection in children: experts’ consensus statement. World J Pediatr 2020; 1–9. doi:10.1007/s12519-020-00343-7.
doi: 10.1007/s12519-020-00343-7
Ranucci M, Ballotta A, Di Dedda U, et al. The procoagulant pattern of patients with COVID-19 acute respiratory distress syndrome. J Thromb Haemost 2020; 10.1111/jth.14854. doi:10.1111/jth.14854.
doi: 10.1111/jth.14854.
Ciceri F, Beretta L, Scandroglio AM, et al. Microvascular COVID-19 lung vessels obstructive thromboinflammatory syndrome (MicroCLOTS): an atypical acute respiratory distress syndrome working hypothesis. Crit Care Resusc 2020; [published online ahead of print, 2020 Apr 15].
Barrett CD, Moore HB, Yaffe MB, Moore EE. ISTH interim guidance on recognition and management of coagulopathy in COVID-19: a comment. J Thromb Haemost 2020; 10.1111/jth.14860. doi:10.1111/jth.14860.
doi: 10.1111/jth.14860.
Shi S, Qin M, Shen B, et al. Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China. JAMA Cardiol 2020; e200950[Epub ahead of print].
Guo T, Fan Y, Chen M, et al. Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19). JAMA Cardiol 2020; e200950doi:10.1001/jamacardio.2020.0950.
doi: 10.1001/jamacardio.2020.0950
Arentz M, Yim E, Klaff L, et al. Characteristics and outcomes of 21 critically ill patients with COVID-19 in Washington State. JAMA 2020; 323:1612–1614.
Stout KK, Daniels CJ, Aboulhosn JA, et al. 2018 AHA/ACC Guideline for the management of adults with congenital heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation 2019; 139:e637–e697.
Ho TBL, Rhodes A. Nitric oxide and prostacyclin in acute interstitial pneumonia. J R Soc Med 2002; 95:35–37.
Gewillig M, Goldberg DJ. Failure of the Fontan circulation. Heart Fail Clin 2014; 10:105–116.
Russell CD, Millar JE, Baillie JK. Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury. Lancet 2020; 395:473–475.
Li F, Cai J, Dong N. First cases of COVID-19 in heart transplantation from China. J Heart Lung Transplant 2020; 39:496–497.
Zhang P, Zhu L, Cai J, et al. Association of inpatient use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers with mortality among patients with hypertension hospitalized with COVID-19. Circ Res 2020; 126:1671–1681.
Geleris J, Sun Y, Platt J, et al. Observational study of hydroxychloroquine in hospitalized patients with Covid-19. N Engl J Med 2020; 382:2411–2418.
Verdoni L, Mazza A, Gervasoni A. An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study. Lancet 2020; 395:1771–1778.
MacLaren G, Fisher D, Brodie D. Preparing for the most critically ill patients with COVID-19: the potential role of extracorporeal membrane oxygenation. JAMA 2020; 323:1245–1246.
Ramanathan K, Antognini D, Combes A, et al. Planning and provision of ECMO services for severe ARDS during the COVID-19 pandemic and other outbreaks of emerging infectious diseases. Lancet Respir Med 2020; 8:518–526.
Sabatino J, Ferrero P, Chessa M, et al. COVID-19 and congenital heart disease: results from a nationwide survey. J Clin Med 2020; 9:E1774.

Auteurs

Roberto Formigari (R)

Pediatric Cardiology and Cardiac Surgery Department, 'Bambino Gesù' Pediatric Hospital, Rome.

Simona Marcora (S)

Pediatric Cardiology, 'Papa Giovanni XXIII' Hospital, Bergamo.

Giovanni Battista Luciani (GB)

Department of Surgery, Dentistry, Pediatrics and Gynecology, University of Verona, Verona.

Silvia Favilli (S)

Pediatric Cardiology, 'A. Meyer' Pediatric Hospital, Florence.

Gabriele Egidy Assenza (G)

Pediatric Cardiology and ACHD Program, Policlinico 'S.Orsola-Malpighi', Bologna.

Gabriele Rinelli (G)

Pediatric Cardiology and Cardiac Surgery Department, 'Bambino Gesù' Pediatric Hospital, Rome.

Giovanni Meliota (G)

Pediatric Hospital, 'Giovanni XXIII' Pediatric Hospital, Bari.

Biagio Castaldi (B)

Pediatric Cardiology, University of Padua, Padua.

Giuseppe Limongelli (G)

Inherited and Rare Cardiovascular Diseases, Department of Translational Medical Sciences, University of Campania 'Luigi Vanvitelli', Monaldi Hospital, Naples.

Serena Flocco (S)

Health Professions Research and Development Unit, IRCCS Policlinico San Danato, Milan, Italy.

Ugo Vairo (U)

Pediatric Hospital, 'Giovanni XXIII' Pediatric Hospital, Bari.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH